Ascentage Pharma Group International (AAPG) Accounts Payables: 2023-2024

Historic Accounts Payables for Ascentage Pharma Group International (AAPG) over the last 2 years, with Dec 2024 value amounting to $12.6 million.

  • Ascentage Pharma Group International's Accounts Payables rose 25.22% to $12.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $12.6 million, marking a year-over-year increase of 25.22%. This contributed to the annual value of $12.6 million for FY2024, which is 22.90% up from last year.
  • Ascentage Pharma Group International's Accounts Payables amounted to $12.6 million in FY2024, which was up 22.90% from $10.3 million recorded in FY2023.
  • Ascentage Pharma Group International's 5-year Accounts Payables high stood at $12.6 million for FY2024, and its period low was $10.3 million during FY2023.
  • In the last 2 years, Ascentage Pharma Group International's Accounts Payables had a median value of $11.4 million in 2023 and averaged $11.4 million.
  • Data for Ascentage Pharma Group International's Accounts Payables shows a peak YoY rose of 22.90% (in 2024) over the last 5 years.
  • Ascentage Pharma Group International's Accounts Payables (Yearly) stood at $10.3 million in 2023, then climbed by 22.90% to $12.6 million in 2024.